HONG KONG, May 12, 2026 - (ACN Newswire via SeaPRwire.com) - Recently, Guotai Junan International Holdings Limited (“Guotai Junan International” or “GTJAI”, Stock Code: 1788.HK), a subsidiary of Guotai Haitong Group, successfully assisted the State Bank of Mongolia in completing a US$100 million Reg S bond tap issuance as the sole global coordinator. This issuance is a tap-on of the State Bank (Mongolia) initial US$ 200 million 3-year bond issued in September 2025. Upon completion of this tap issuance, the outstanding size of the bond has increased to US$300 million.The issuer has been assigned a “B1” issuer rating by Moody’s, with a “stable” outlook, aligned with Mongolia’s sovereign rating. This issuance also received formal support letters from the Ministry of Finance of Mongolia and the Central Bank of Mongolia. The tap offering was priced at a yield of 8.5%, representing a significant improvement from the original issuance's level of 8.9%. This not only reflects the solid financial fundamentals of the State Bank (Mongolia), but also signals continuously growing confidence among international investors in Mongolia’s economic prospects.The successful completion of this bond tap issuance marks a significant milestone for the State Bank (Mongolia) in the international capital markets. It also represents another in-depth collaboration between the bank and GTJAI, following the latter’s assistance in the bank’s initial US$200 million 3-year bond issuance in September 2025, demonstrating the high level of mutual trust and long-term rapport between the two parties. Amid a complex and volatile global capital market environment, GTJAI precisely seized the market window and efficiently executed the project. This not only further strengthens the Company’s business presence in facilitating offshore bond financing for issuers outside the Greater China region, but also fully showcases its capabilities in professional pricing, global investor resource integration, and cross-market comprehensive financial services in the global capital markets.About GTJAIGuotai Junan International (Stock Code: 1788.HK), a subsidiary of Guotai Haitong Group, is the market leader and first mover for internationalization of Chinese Securities Company as well as the first Chinese securities broker listed on the Main Board of The Hong Kong Stock Exchange through initial public offering. Based in Hong Kong with subsidiaries in Singapore, Vietnam and Macau, GTJAI’s business covers major markets around the world, offering high-quality and diversified comprehensive financial services for clients' overseas asset allocation. Core business includes wealth management, institutional investor services, corporate finance services, investment management and other business. GTJAI has been assigned “Baa2” and “BBB+” long term issuer rating from Moody and Standard & Poor respectively, as well as an MSCI ESG “AAA” rating, Wind ESG “A” rating and SynTao Green Finance “A” rating in ESG. Additionally, its S&P Global ESG score leads 81% of its global peers. The controlling shareholder, Guotai Haitong Securities (Stock Code: 601211.SH/ 2611.HK), is the comprehensive financial provider with a long-term, sustainable and overall leading position in the China’s capital markets. For more information about GTJAI, please visit https://www.gtjai.com. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年5月12日 - (亚太商讯 via SeaPRwire.com) - 近日，国泰海通集团下属公司国泰君安国际控股有限公司（"国泰君安国际"，股份代号：1788.HK）作为独家全球协调人，圆满协助蒙古国家银行（State Bank of Mongolia）完成1亿美元Reg S债券增发。本次发行为蒙古国家银行2025年9月首次2亿美元3年期债券的增发，发行完成后，该期债券存续规模增至3亿美元。发行人获穆迪授予"B1"发行人评级，评级展望"稳定"，与蒙古主权评级一致。本次发行亦获得蒙古财政部及蒙古中央银行出具的正式支持函。本次增发定价收益率为8.5%，较原发行8.9%的水平显著优化，既体现蒙古国家银行稳健的财务基本面，也反映国际投资者对蒙古经济前景的信心持续提升。 本次债券增发顺利落地，是蒙古国家银行在国际资本市场的重要里程碑，亦是国泰君安国际继2025年9月助力其首次完成2亿美元3年期债券后，与该行的再度深度合作，彰显双方高度互信与长期默契。面对复杂多变的全球资本市场环境，国泰君安国际精准把握市场窗口、高效完成项目执行，既进一步巩固了公司服务非大中华区域发行人开展境外债券融资的业务布局，也充分展现了其在全球资本市场的专业定价、全球投资者资源整合及跨市场综合金融服务能力。关于国泰君安国际国泰海通集团下属公司国泰君安国际（股票代号：1788.HK），是中国证券公司国际化的先行者和引领者，公司是首家通过IPO于香港联合交易所主板上市的中资证券公司。国泰君安国际以香港为业务基地，并在新加坡、越南和澳门设立子公司，业务覆盖全球主要市场，为客户境外资产配置提供高质量、多元化的综合性金融服务，核心业务包括财富管理、机构投资者服务、企业融资服务、投资管理等。目前，国泰君安国际已分别获得穆迪和标准普尔授予"Baa2"及"BBB+"长期发行人评级，MSCI ESG"AAA"评级, Wind ESG"A"评级及商道融绿ESG"A"评级，同时其标普全球ESG评分领先全球81%同业。公司控股股东国泰海通证券（股票代号：601211.SH/2611.HK）为中国资本市场长期、持续、全面领先的综合金融服务商。更多关于国泰君安国际的信息请见:https://www.gtjai.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - May 12, 2026) - Casa Minerals Inc. (TSXV: CASA) (OTCQB: CASXF) (FSE: 0CM) ("CASA" or the "Company") is pleased to report that it has received aggregate gross proceeds of $432,777.30 to date in 2026 through the exercise of 4,453,364 common share purchase warrants (the "Warrants").The Warrants were originally issued pursuant to the Company's private placements completed in April of 2025 and February of 2026. Each Warrant entitled the holder to acquire one common share of the Company upon exercise.Net proceeds will be deployed to advance Casa's 2026 exploration programs at the Congress Gold Mine in Arizona and the Arsenault Copper-Gold-Silver Project in British Columbia, and for general working capital purposes."The continued support from our warrant holders is greatly appreciated," said Farshad Shirvani, President and Chief Executive Officer. "This additional capital meaningfully strengthens our balance sheet as we mobilize for an aggressive 2026 drilling and exploration season across our core projects."About Casa Minerals Inc.Casa Minerals Inc. is a mineral exploration company focused on gold, copper, and strategic minerals exploration in North America. The Company holds a 90% interest in the historic Congress Gold Mine in Arizona and is advancing multiple projects in British Columbia, including the Arsenault copper-gold-silver project. Casa's experienced management team is committed to creating shareholder value through the discovery and development of economic mineral deposits. For more information, please visit: www.casaminerals.comON BEHALF OF THE BOARD OF DIRECTORSFarshad Shirvani, M.Sc. GeologyPresident, CEO and DirectorFor more information, please contact:Casa Minerals Inc.Farshad Shirvani, President & CEOPhone: (604) 678-9587Email: contact@casaminerals.comNEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297081 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年5月12日 - (亚太商讯 via SeaPRwire.com) - 全球知名24小时连锁健身品牌Anytime Fitness（"公司"）近年于亚太区发展强劲，受惠于后疫情时代公众健康意识显著提升，市场拓展步伐持续加快。其中，香港作为策略性增长市场，预计年内场馆总数达50间之里程碑，另有逾25间已获资金支持，未来数年更有潜力增设30至40间场馆。同时，公司预测未来二至三年，亚太区场馆总数将达2,500至3,000间，展现其对区域市场的长期承诺与信心。真正全球品牌 区域专业赋能Anytime Fitness作为真正的全球品牌，业务覆盖7大洲共42个国家及地区，会员可于全球各场馆无缝畅行。不同于同业仅具国际化布局，Anytime Fitness构建了全球互联的健身生态体系，兼具规模优势、服务一致性，以及以会员为本的创新能力。于亚太区，Inspire Brands Asia（"IBA"）作为Anytime Fitness在香港、新加坡、泰国、菲律宾、印尼、越南、台湾及马来西亚等重点市场的总特许经营商，推动业务增长。此架构既有助于强化区域执行力，又能维持全球品牌标准的一致性。以社区为本 复制新加坡经验至香港Anytime Fitness的核心理念是将健身服务带入社区，并提供便捷、无压力的健身体验，此模式于全球验证成功。IBA集团首席营运总裁Ryan Cheal表示："新加坡作为区域内高度成熟的市场，已授出约200个特许经营权，营运场馆逾160间，其市场渗透率与消费模式为香港提供了清晰的发展蓝图。香港与新加坡市场高度相似，且人口基数更大，极具社区发展潜力。我们有信心复制新加坡的成功经验，预计香港于突破50间场馆之临界点后，网络效应将带动更快增长。"特许经营驱动规模扩张 全链支持合作伙伴营运模式方面，Anytime Fitness 采用特许经营与直营并行。目前香港约50%场馆为品牌直营，此举旨在深入理解本地市场，以更有效地支持特许经营合作伙伴。另外，新加坡市场的直营比例约20%，此结构确保公司于快速扩张的同时，能维持高品质的服务标准与品牌一致性。公司特许经营生态提供全链支持，包括：- 选址及场馆建设；- 设备配置及营运筹备；- 营销及会员招募；- 特许经营合作伙伴培训及业务指导。此整合模式既可确保会员体验的一致性，又能实现迅速且可持续的扩张。目前，公司约80%的新增场馆来自现有特许经营商，零售、餐饮等行业投资者亦呈转投健康产业之趋势，印证了该模式的强大吸引力与市场对其增长潜力的认可。科技赋能会员体验 构建全方位健康生态面对智慧化趋势，Anytime Fitness积极以科技提升服务价值。为提升会员体验，Anytime Fitness 持续投资于科技及个人化的健康方案，其新一代会员应用程式整合以下功能：- 个人化训练计划；- 课堂及教练预约；- 恢复指导及营养建议。此生态系统亦配备多种仪器，例如Evolt身体成分分析仪，可测量逾40项生物指标，令会员更深入掌握自身健康与健身进展。目前，应用程式日均会员使用率约30%至35%，有效巩固用户参与度与黏性。洞悉香港会员：力量训练、身心健康与生活方式最新会员洞察显示，香港会员的健身目标优先级正在转变：- 57%的会员（每五人中有三人）以力量训练为首要目标；- 16%的会员（每六人中有一人）则更注重整体健康，包括心理健康及整体生活方式的改善。上述趋势反映出消费者行为的结构性转变：健身不再只是可有可无的选择，而是现代生活不可或缺的一部分。聚焦"健康刚需"与"人性化连接" 行业前景稳健向好尽管宏观经济仍显复杂，公司对行业前景保持乐观。Ryan指出，当前健身人群持续扩大，长者参与健身人数逐步上升，健康意识亦不断提升；大众消费优先次序正经历结构性转变，健康与健身已由"可选消费"转变为"生活必需"。值得一提的是，年轻族群对健康、保健与长寿的投资意愿尤为显著，为行业带来穿越周期的韧性。展望未来，Anytime Fitness将持续进行产品与服务创新。公司已于上月推出全新场馆设计，强化力量训练与运动恢复区域，并计划于明年进一步优化营养指导服务。Ryan总结："科技时代，Anytime Fitness 将坚持‘人性化连接’的核心价值，以便利、友善、专业的服务，令更多人建立恒常运动习惯，开启健康生活。我们对亚太及香港市场充满信心，相信未来发展将更快速、更具创新性。"关于Anytime FitnessAnytime Fitness是全球规模最大、发展最快的健身品牌之一，每年新增场馆约300间，现已覆盖全球7大洲42个国家和地区的逾5,600间场馆，为逾500万会员提供服务。无论会员身处何方，该品牌都能全年365天、全天24小时开放，随时为会员于场馆、家中和移动设备上，提供他们所需的个性化、可负担的健康保健训练、指导、营养和恢复服务。所有特许经营的场馆均为独立所有及营运，会员可以进入全球任一Anytime Fitness场馆。如欲索取更多资料，请浏览以下网址：https://www.anytimefitness.com/。新闻垂询：Inspire Brand AsiaJerry Chow 电邮: Jerry.chow@inspirebrandsasia.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

MUMBAI, INDIA, May 12, 2026 - (ACN Newswire via SeaPRwire.com) - CleverTap, the all-in-one customer engagement platform, has won Silver at the Thailand MarTech Awards 2026 in the Impact MarTech category, in partnership with Rabbit Rewards, the loyalty and lifestyle platform for Bangkok’s BTS Skytrain and a widely used commuter ecosystem in Southeast Asia.The recognition highlights how CleverTap and Rabbit Rewards have transformed customer engagement by building a real-time, agentic engagement model powered by autonomous decisioning, designed to serve millions of commuters in a high-frequency environment.Rabbit Rewards operates at the intersection of daily commuting, payments, and lifestyle services, where user behavior shifts constantly based on routine, timing, and location. Traditional campaign-led approaches, built on static segmentation and fixed schedules, were unable to keep pace and often resulted in delayed or irrelevant engagement.To address this, Rabbit Rewards partnered with CleverTap to implement a real-time decisioning layer that continuously interprets live behavior and determines the next best action for each user.With CleverAI™, and its suite of tools — including IntelliNODE and Best Time Optimization among others — Rabbit Rewards deployed trigger-based, omnichannel journeys across push notifications, in-app messaging, email, and SMS. These journeys span onboarding, renewals, promotions, and re-engagement, and adapt continuously to commuter behavior.The shift to real-time, behavior-led engagement delivered clear, measurable outcomes:85% uplift in click-through rates (CTR)62.6% week-4 repeat transactions among engaged users, compared to 18.7% for non-engaged users2.4% of total transactions directly influenced by CleverTap-powered engagementBeyond these results, Rabbit Rewards significantly improved the quality of customer engagement. Communication became more timely, contextual, and aligned with commuter needs, strengthening trust and positioning the platform as a more intuitive, lifestyle-oriented companion for daily users.“Our vision has always been to make everyday commuting more seamless, rewarding, and relevant for our users. Through our partnership with CleverTap, we have successfully transitioned from traditional campaign execution to a real-time engagement model that understands and responds to commuter behavior in the moment.CleverAI™ has enabled us to deliver more personalized and timely experiences at scale, strengthening both customer engagement and long-term loyalty. This collaboration goes beyond technology — it is about ensuring Rabbit Rewards shows up for our members in ways that feel personal, timely, and genuinely useful throughout their daily journeys,” said Kamolwan Korphaisarn, Program Director, Rabbit Rewards“Enterprises today sit on a surplus of data, but turning those data points into timely, meaningful action remains a big challenge. With CleverAI™, we’re enabling brands to move beyond static campaigns to intelligent systems that continuously interpret behavior, determine the next best action, and deliver truly personalized experiences in real time. Our work with Rabbit Rewards shows how this approach drives stronger engagement while enabling seamless, context-aware customer journeys at the scale of the individual,” said Anand Jain, Co-founder and Chief Marketing Officer, CleverTap.About Rabbit RewardsRabbit Rewards is Thailand’s leading loyalty and lifestyle platform built around Bangkok’s BTS Skytrain ecosystem, one of Southeast Asia’s busiest urban transit networks serving millions of daily commuters.The platform connects commuting, payments, and everyday lifestyle experiences into a single ecosystem, enabling members to access rewards, offers, and partner benefits across Bangkok.As part of BTS Group Holdings, Rabbit Rewards serves a diverse member base ranging from daily riders and students to tourists and lifestyle-focused members, making it a deeply embedded companion in Bangkok’s urban lifestyle.Rabbit Rewards continues to evolve its customer engagement capabilities to deliver more contextual, real-time experiences that align with the rhythm of everyday commuting and lifestyle needs.For more information, visit rabbitrewards.co.thAbout CleverTapCleverTap is the world’s leading AI-first, all-in-one customer engagement and retention platform, helping brands turn data into lasting customer relationships. Powered by its proprietary CleverAI™: Decisioning Engine and Agentic AI-verse, CleverTap enables organizations to maximize customer lifetime value at scale. Its unified platform brings together AI-powered segmentation, personalization, experimentation, journey orchestration, and deep analytics—seamlessly integrated with 100+ leading martech solutions.Leading brands such as Burger King, Levi’s, IKEA, Decathlon, Domino’s, Jio, Carousell, AIA Thailand, Sasom, 12Go, and Ngern Tid Lor, rely on CleverTap to drive measurable growth through meaningful customer engagement. With backing from global investors including Accel, Peak XV Partners, Tiger Global, CDPQ, and 360 One, CleverTap has presence across US, Europe, the Middle East, Latin America, and Asia.For more information, visit clevertap.com or follow us on:LinkedIn: https://www.linkedin.com/company/clevertap/X: https://twitter.com/CleverTapFor more information:ADITYA SANYALDirector, Digital Marketing, CleverTap+91 9177110080aditya.sanyal@clevertap.comASHMIT CHAUDHARYAssociate Consultant, Archetype+91 8850752121ashmit.chaudhary@archetype.co Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, May 12, 2026 - (ACN Newswire via SeaPRwire.com) - May 11, 2026, Gold Peak Technology Group Limited (SEHK: 40) completed a syndicated green and sustainability-linked loan facility (the “GSLL Facility”) of HK$675 million with 10 major banks. With Hang Seng Bank Limited as the mandated lead arranger and bookrunner, Shanghai Commercial Bank Limited is the mandated lead arranger and Malayan Banking Berhad the lead arranger. Other arrangers include Chang Hwa Commercial Bank, Ltd. Hong Kong Branch; Bank of Dongguan International Limited; China Zheshang Bank Co., Ltd. Hong Kong Branch; Taiwan Cooperative Bank, Ltd. Hong Kong Branch; Taiwan Shin Kong Commercial Bank Co., Ltd., Hong Kong Branch; First Commercial Bank, Ltd., Macau Branch; and Hua Nan Commercial Bank, Ltd., Offshore Banking Branch.Notwithstanding the challenging global environment, this HK$675 million GSLL Facility underscores strong confidence and backing from the banking sector in Gold Peak’s commitment to, and track record of, upholding and advancing Environmental, Social, and Governance (“ESG”) principles.Victor Lo, Chairman & Chief Executive of Gold Peak, said, “Gold Peak remains steadfast in its commitment to long-term sustainable development and has consistently demonstrated its ability to deliver in this area. The establishment of the GSLL Facility not only validates our strategic direction but also enables us to explore innovative financing options and adopt operational best practices that will drive sustainable business growth.”Dr Brian Li, Vice Chairman and Executive Vice President of Gold Peak, commented, “As a prominent player in the batteries, audio, and electronics industries, Gold Peak is committed to embedding sustainability into every aspect of its operations. We have made solid and measurable progress in advancing our sustainability strategy, reflecting our dedication to responsible corporate citizenship and long-term value creation.”“We champion the use of rechargeable batteries to reduce waste. Our GP Recyko rechargeable range has been met with strong market acceptance, and we are continuously improving our charging efficiency to enable full charging in just one hour, a boost to shifting the consumers’ habit from single-use batteries to rechargeables.”“We continued to reinforce our packaging sustainability efforts by replacing plastic packaging with paper-based alternatives for more than 1,000 GP-branded consumer battery products across Europe. As a result of this initiative, we achieved an annual reduction of 48 tons of plastic and 30 tons of material waste.”GP Energy Tech, the Group’s sustainable energy solutions business, reached a key milestone with the opening of our first Nickel Zinc (NiZn) manufacturing facility in Dongguan, China, in January 2026. This marks an important step toward positioning Gold Peak to develop next- generation NiZn battery solutions, engineered to enhance immediate power performance through high power density, improved recyclability, and non-flammable characteristics.The NiZn batteries are designed to provide reliable, sustainable power for Uninterruptible Power Supply (UPS) systems for data centers and other critical infrastructures. Through the GSLL Facility, the Group will receive funding to further advance the NiZn initiative — supporting progress toward a safer and more sustainable future.Gold Peak views sustainability as a crucial value driver for achieving profitable, long-term growth. In FY24/25, it achieved a 4% year on year reduction in Scope 1 and Scope 2 greenhouse gas emissions compared to FY23/24 baseline year. It remains committed to its interim and long-term reduction targets as follows:- a 20% reduction by 2030 compared to the FY23/24 baseline;- a 60% reduction by 2040; and- the achievement of net-zero operational emissions (i.e., 100% reduction) by 2050.Among many sustainability awards, six of the Group’s battery manufacturing facilities have achieved Zero Waste to Landfill Platinum and Gold validation from UL Solutions, demonstrating its commitment to diverting 95-100% of waste from landfills through effective waste reduction and diversion strategies. Additionally, GP Batteries and GP Energy Tech have gained EcoVadis Bronze medal during FY25/26. The Group is also continuously ramping up the solar panels in factories to realize its decarbonization goals.Regina Lee, Head of Commercial Banking at Hang Seng Bank Limited, said, “This syndicated facility reflects the market’s confidence in Gold Peak’s long-term strategy and sustainability efforts. Hang Seng Bank is honoured to act as sole mandated lead arranger and bookrunner for a green and sustainability-linked loan facility, delivering a structure that incentivises performance against clear sustainability targets and supporting the Group’s continued investment in rechargeable battery manufacturing. Building on our long-standing relationship with Gold Peak, we’ll continue to work closely with the Group to align financing with sustainability outcomes, creating long-term value for stakeholders and the wider community.”The 3-year GSLL Facility features a tiered incentive mechanism that rewards progress toward sustainability targets, with Gold Peak eligible for an interest rate reduction upon achievement. Gold Peak plans to deploy the proceeds to further strengthen its financial position, accelerate the expansion of its rechargeable battery and sustainable energy solutions businesses, support long-term investment in advanced manufacturing technologies, drive operational excellence, and deepen its commitment to green and sustainable business practices.(Center) Brian Li, Vice Chairman and Executive Vice President of Gold Peak, signed the GSLL Facility of HK$675 million with 10 major banks.(7th from the left) Victor Lo, Chairman and Chief Executive of Gold Peak, expressed gratitude to the banks for their continued and unwavering support of the GSLL Facility.Gold Peak Technology Group Limited Charlotte WongSenior Manager, Corporate Communications Tel: (852) 2485 5328Email: charlotte_wong@goldpeak.comAJA Capital LimitedAvy Yu / Janet LouieTel: (852) 9500 4443 / (852) 9155 5615Email:avy.yu@ajacapital.com.hk / janet.louie@ajacapital.com.hkAbout Gold PeakGold Peak Technology Group is a global battery and electronics company with an aspiration to become one of the leaders in providing energy and sound solutions that enlighten and empower lives, and with sustainability as a focus.The parent company, Gold Peak Technology Group Limited (SEHK: 40), was established in 1964 and has been listed on the Stock Exchange of Hong Kong since 1984. Gold Peak holds a majority stake at 86.18%* in the Singapore-listed GP Industries Limited as its major industrial investment vehicle and operates manufacturing, R&D, marketing and distribution operations in more than 10 countries around the world.Gold Peak Technology Group Limited not only develops its consumer batteries, electronics and audio products, but also puts great emphasis on R&D of new rechargeable battery and B2B battery technologies. The Group has built renowned brand names for its major product categories, including GP batteries, GP Recyko batteries, KEF premium audio products and Celestion professional speaker drivers.www.goldpeak.com(* shareholding % as at 11 May 2026) Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, May 11, 2026 - (ACN Newswire via SeaPRwire.com) - The fifth International Healthcare Week (IHW), organised by the Hong Kong Trade Development Council (HKTDC), opens today, featuring two flagship events. The sixth Asia Summit on Global Health (ASGH) is being held today and tomorrow (11 and 12 May) at the Hong Kong Convention and Exhibition Centre (HKCEC) under the theme “Fuelling Healthcare Breakthroughs”. The summit convenes over 90 influential international healthcare officials, research and medical experts, start-ups, investors, and business leaders from related industries to explore global healthcare trends, with a focus on frontier technologies, AI breakthroughs, pandemic preparedness, silver health, as well as innovation in Chinese medicine, in alignment with the National 15th Five-Year Plan. Another flagship event, the 17th Hong Kong International Medical and Healthcare Fair (Medical Fair), also opens today (11 to 13 May) under the theme “Innovations Boosting Smart Health Experience”, featuring some 300 exhibitors from 10 countries and regions. The Fair spotlights MedTech, GeronTech and Preventive Healthcare, showcasing the latest medical innovations integrating artificial intelligence and robotics, fostering global exchange in healthcare innovation and reinforcing Hong Kong’s strengths as a research and commercial hub.Prof Frederick Ma, Chairman of the HKTDC, said in his welcome remarks: “There is nowhere better than Hong Kong, as a major international hub for financing and innovation, to explore areas of global collaboration in the health arena, and to showcase related business opportunities for investors and project owners. As a superconnector and super value-adder, Hong Kong has a long track record of helping companies and innovations break through. The theme we have adopted this year, ‘Fuelling Healthcare Breakthroughs’, highlights this vital role. The ASGH was created to nurture partnerships and knowledge exchange that can drive real change and create a better world. This year’s agenda also complements the healthcare priorities set out in China’s new 15th Five-Year Plan, supporting national development. Among the diverse topics at ASGH 2026 are sessions examining AI-enabled diagnosis and treatment, biomedical innovation, the growth of the silver health economy, traditional Chinese medicine and much more.”John Lee, Chief Executive of the HKSAR, said in his opening remarks: “Hong Kong, under the ‘one country, two systems’ principle, is investing in healthcare and, in doing so, investing in the future of our people and our economy. Our status as a leading hub for scientific innovation is unrivalled in Asia. And our strengths are magnified by our core position in the Guangdong-Hong Kong-Macao Greater Bay Area. That is the cluster city development integrating 11 dynamic cities in southern China. It boasts a collective economy that rivals that of the world's 10th-largest nation. In pursuit of medical innovation, Hong Kong complements the strategies set out in the National 15th Five-Year Plan. The Plan optimises an evaluation and approval mechanism for innovative drugs and supports their clinical application. The goal is to develop Hong Kong into a health and medical innovation hub. Central to this ambition is the rapid expansion of our clinical trial capabilities, the vital engine that drives biomedical R&D from the laboratory to the bedside.”Prof Zeng Yixin, Vice Minister of the National Health Commission of the People’s Republic of China, delivered special remarks: “Hong Kong has extensive experience in undergraduate medical education and post-graduate training, and enjoys a strong reputation in the Asia-Pacific region. Medical talent training system on the mainland is also undergoing deep reforms and striving to move towards high-quality development. Hong Kong has many experiences and practices that are worthy of in-depth exchange and reference, which will certainly promote mutual enhancement and progress.”Global leaders convene to explore collaboration opportunitiesThis morning’s Plenary Session I: Strengthening Pandemic Preparedness through Global Collaboration, featured keynote speech by Prof Lo Chung-mau, Secretary for Health of the HKSAR government, who said: “Hong Kong has long been recognised for the quality and efficiency of our healthcare system. We consistently rank at the top of global health indices, with a life expectancy that remains among the highest in the world, with women over 88 years and men about 83 years in 2024. Our public healthcare system serves as a robust safety net, ensuring universal health coverage for all at a very low cost. The National 15th Five-Year Plan calls for a health-first development strategy. Hong Kong is fully aligned and will continue to contribute to this national vision through our work in pandemic preparedness and medical innovation.”Prof Leo Poon, Daniel C K Yu Professor in Virology at the School of Public Health of the University of Hong Kong and Co-Director of the Hong Kong Jockey Club Global Health Institute, moderated the session. Distinguished speakers included Prof Ibrahim Abubakar, Vice-Provost (Health) and Professor of Infectious Disease Epidemiology at University College London; Feng Lan, Vice President, China Pharmaceutical Innovation and Research Development Association; Dr Leung Yiu-hong, Head of Emergency Response and Programme Management Branch, Department of Health of the HKSAR government; Dr Kumanan Rasanathan, Executive Director of the WHO Alliance for Health Policy and Systems Research; Prof Wang Yu, Chairman of the Chinese Foundation for Hepatitis Prevention and Control, also Former Director-General, Chinese Centre for Disease Control and Prevention; and Dr In-Kyu Yoon, Deputy Director General for Integrated Development and Pandemic Preparedness at the International Vaccine Institute. They discussed key strategies to strengthen the resilience of the global health system in response to future pandemics. Dr Kumanan Rasanathan said: “Public health agencies need to maintain scientific independence to synthesize, act upon, and provide advice based on the best available science. They also require operational flexibility because, during a pandemic or outbreak, it is not sufficient to rely solely on strategies used for previous outbreaks.”Plenary Session II: Fuelling Healthcare Breakthroughs was moderated by Victor Chu, Chairman and CEO of First Eastern Investment Group. Speakers included Clara Chan, CEO of Hong Kong Investment Corporation Limited; David Lau, Vice Chair of Investment Banking for Asia Pacific and Head of Healthcare Investment Banking for Asia Pacific at JP Morgan Securities; Dr Inna Menkova, Chief Executive Officer, Allogenica; Jonathan Symonds, Chairman of the Board of GSK; and Theresa Tse, Chairwoman of the Board, Sino Biopharmaceutical Limited; They examined investment trends and market transformation in biopharmaceuticals and explored how cross-sector collaboration can drive healthcare breakthroughs.One of the highlights this afternoon, the Dialogue with Global Pioneer in Health session, featured 2013 Nobel Prize laureate in Chemistry, Prof Michael Levitt, Robert W and Vivian K Cahill Professor in Cancer Research at Stanford University. He shared insights into his research and the future of technology-driven healthcare innovation, exploring how biological intelligence is shaping the future of healthcare. He said: “One of the secrets of successful evolution is to be as diverse as possible. This diversity then leads to intelligence.”Thematic sessions spotlight cutting-edge healthcare innovation and AI applicationsAs the global healthcare industry accelerates towards technology-driven transformation and industrial upgrading, multiple thematic sessions at the summit focus on the application of innovative technologies across the sector. Topics include AI-enabled healthcare, medical robotics and devices, cell and gene therapies, biomedical, and the silver economy, showcasing the latest market trends and aligning with the National 15th Five-Year Plan to advance the development of a “Healthy China” and foster AI and healthcare innovation. The first day featured a dedicated session, The Next Frontier in China's Healthcare Industry, moderated by Nisa Leung, Managing Partner of Aulis Capital, with speakers including Mark Gavin Lotter, Founder and CEO of Nuance Pharma; Wu Hao, Executive Director and Co-President of Tigermed; and Seth Zhang, Founder and CEO of MediTrust Health. They discussed strategies to drive the development of the Chinese Mainland healthcare sector. Wu Hao said: “By giving China-led industry data and applications greater exposure and participation on the global stage, Chinese enterprises can take a seat at the table and become true leaders.”Several thematic sessions spotlight the large-scale application of AI in healthcare. These include this afternoon’s sessions: Intelligence at Scale: How AI is Powering Real-World Healthcare Revolution, moderated by Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia and CEO of Gleneagles Hospital Hong Kong, featured speakers including Prof Joshua Ho, Assistant Dean (Innovation and Technology Transfer) in the Li Ka Shing Faculty of Medicine at the University of Hong Kong; and Reshaping Tomorrow’s Healthcare: Advances in Medical Robotics and Devices, further explored the transformative role of AI in medical robotics and next-generation medical devices, showcasing cutting-edge innovations and breakthrough developments. Tomorrow afternoon’s session, Transforming Healthcare through Digital Health & AI Innovations, with speakers from Healthtech Finland, Heidi Health, Pfizer, The Hong Kong Polytechnic University and other leading organisations, will offer multi-dimensional insight into AI applications and breakthroughs in the healthcare field.A new session this year, CSO Insights: Catalysing Scientific Breakthroughs and Investments for Future Health, will bring together leading scientists from global pharmaceutical companies, including Dr Li Xiang, Senior Vice President, Co-President and Chief Scientific Officer of Innovative Medicines Division at Fosun Pharma, to discuss transforming research breakthroughs into real-world healthcare applications.Building on last year’s Silver Health Chapter, tomorrow will feature the session Unlocking Growth in Silver Health: From Precision Medicine to Smart Ageing Innovations. Speakers include Prof Christopher Chao, Vice President (Research and Innovation) of the Hong Kong Polytechnic University; Prof Brian Kennedy, Director of the Centre for Healthy Longevity at the National University Health System, Singapore; and Zhang Junjie, Vice President of Ant Group and President of Healthcare Business Group. They will share insights into ageing-related disease prevention and solutions.Other sessions also cover a wide range of cutting-edge topics, including Driving Chinese Medicine Development Through Standardisation and Innovation, and IP Financing and Trading for Pharmaceutical and Health Technology. These thematic sessions examine the latest developments and trends in the healthcare industry from multiple perspectives, promoting exchanges among scientific research, market applications and industry policy. During the session From Detection to Cure: Accelerating Innovations for Rare Diseases, Prof Liang Zicai, Founder and Chairman of Suzhou Ribo Life Science, will explore how innovative diagnostics and treatments are bringing new hope to patients. Another session, Charting the Future: A New Era in Gene and Cell Therapies, brought together Dr Li Xiang, Founder and CEO of XellSmart, and Dr Zhu Tian, Co-founder and CEO of GenEditBio, who shared the latest advancements in stem cell biology and genome editing platforms with other guests. A global platform for healthcare resource matching, empowering pharmaceutical and healthcare companies to expand their businessIn addition to symposium sessions, some 180 healthtech companies from 12 countries and regions are showcasing innovative projects and solutions at the ASGH Business Hub and InnoHealth Showcase. At the same time, Project Pitching provides start-ups with opportunities to connect with investors, while the ASGH Deal-making facilitate one-on-one meetings to match global capital with healthcare projects. Participants can also access professional advice at the “GoGlobal Connect” and Business of Healthcare Advisory Zone, enabling companies to develop more targeted strategies for business expansion.Medical Fair showcases diverse AI-driven health solutions, with smart ageing products surge twofoldThe 17th Hong Kong International Medical and Healthcare Fair, organised by the HKTDC and co-organised by the Hong Kong MedTech Association, opened alongside ASGH. With the theme Innovations Boosting Smart Health Experience, the Fair brings together some 300 exhibitors from 10 countries and regions, including Hong Kong, the Chinese Mainland, Taiwan, Korea, as well as new participants from Macao, Australia, Canada, New Zealand, Vietnam and the United States, highlighting Hong Kong’s strengths as an international medical innovation hub.The Fair focuses on three key areas: MedTech, GeronTech and Preventive Healthcare, presenting a comprehensive showcase of the latest medical and healthcare equipment, products and application solutions from around the world. For MedTech, Neuroptek Corporation Inc from Canadian pavilion (Booth No.: 3E-D16) showcases the brand new EyeMirage, a solution that extends professional ophthalmic vision examinations beyond the clinic. By leveraging the computing power and camera technology of smartphones, the system enables users to conduct high-quality vision tests in settings such as homes and schools. Meanwhile, HKG epiTherapeutics Limited (Booth number: 3E-E06), from the Hong Kong Science and Technology Parks, presents a DNA methylation analysis technology designed for the early screening of liver cancer. The solution can identify and distinguish differential methylation features among liver cancer, blood and normal tissues. Its clinical research findings have been published in leading international academic journals[1], demonstrating a sensitivity of 88.5% for early-stage liver cancer and 95.7% for late-stage cases, representing one of the highest performance levels globally in methylation-based liver cancer early screening.In the field of GeronTech, the exhibits span a wide range of products, including smart rehabilitation robots, AI-powered mental health assessment systems, smart elderly care solutions and home-based care devices, fully addressing the evolving market needs of the silver economy. Hanshin Technology Limited (Booth No.: 3E-D13) introduces a Smart Shower Robot, which enhances safety and comfort for the elderly during bathing through intelligent design, while also easing caregivers’ workload and supporting the practical adoption of smart care solutions. Notably, the number of smart ageing products exhibited this year has more than doubled compared with the last edition, underscoring strong and growing market demand.In Preventive Healthcare, an exhibitor from Chinese Mainland, Guangzhou Supbio Bio-Technology and Science Co., Ltd. (Booth No: 3E-E19), presents the world’s first HIV-1 DNA quantitative testing kit approved for market launch by the National Medical Products Administration (NMPA). Designed to address increasingly complex HIV testing needs, the solution provides a stable and reliable full-disease-course testing approach, supporting an integrated and innovative model that spans prevention, treatment efficacy assessment and the exploration of functional cure through precision diagnostics.The Medical Fair features more than 50 themed forums and seminars, including topics such as “HKMTA Medical Fair Forum 2026: The Medtech Solutions - Greater Bay Area & Overseas”, co-organised with the Hong Kong MedTech Association, to be held tomorrow morning (12 May), followed by the afternoon session “ASEAN Gateway: Navigating Regulations, Capital and Distributions from Hong Kong”. On Wednesday (13 May), sessions such as “Decoding the Demand for Gerontechnology” will also take place. Industry experts will share the latest insights and market trends, and the exhibition will provide an ideal platform for professionals to network and explore new business opportunities. The exhibition will continue to adopt the “EXHIBITION+” hybrid model. The physical fair will take place from 11 to 13 May at the HKCEC. Global exhibitors, industry professionals, and buyers can engage in discussions via the “Click2Match” smart business matching platform from 4 May until 20 May.Photo download: https://bit.ly/4tsy9JsThe sixth Asia Summit on Global Health, jointly organised by the HKSAR government and the Hong Kong Trade Development Council, is held from 11 to 12 May at the Hong Kong Convention and Exhibition Centre under the theme “Fuelling Healthcare Breakthroughs.”Prof Frederick Ma, HKTDC Chairman, delivered the welcome remarks.John Lee, Chief Executive of the HKSAR, delivered the opening remarks.Prof Michael Levitt, 2013 Nobel Laureate in Chemistry, and the Robert W and Vivian K Cahill Professor in Cancer Research at Stanford University, shared his insight.ASGH Deal-making has facilitated one-on-one meetings, both online and offline, to channel capital to healthcare projects and promote collaboration.The ASGH Business Hub and InnoHealth Showcase have featured around 180 healthtech companies from 12 countries and regions.Under the theme Innovations Boosting Smart Health Experience, the 17th Hong Kong International Medical and Healthcare Fair (Medical Fair) highlights MedTech, GeronTech & Preventive Healthcare, with some 300 exhibitors from 10 countries and regions.On the first day of the Medical Fair, a series of forums and seminars were held, including “Digital Pulse, Preventive Future: When Wearable Technology Meets Chinese and Western Medicine Collaboration and AI” .The session featured Mr. Paul Anthony Yuen, Director of Dayton Industrial Co., Ltd., who joined academic experts in sharing insights into the latest developments in the field.Led by the Hong Kong Science and Technology Parks Corporation (HKSTP), DRESIO Limited showcases its AI-powered physiotherapy motion analysis system.Exhibitor from Canada bring medical technologies, highlighting clinical applications and solutions.Medical Fair exhibitor Green Life Technology Ltd (Booth No.: 3D-D24) showcases the world’s first product integrating inversion technology and 3D resonance technology, which has been successfully adopted by massage practitioners and therapists in Germany.WebsitesInternational Healthcare Week: https://internationalhealthcareweek.hktdc.com/enThe Asia Summit on Global Health: https://www.asiasummitglobalhealth.com/conference/asgh/en?ref_source=GrayMenu&ref_medium=vep-conferenceHong Kong International Medical and Healthcare Fair: https://www.hktdc.com/event/hkmedicalfair/en?ref_source=GrayMenu&ref_medium=vep-tradeshowList of Product: https://www.hktdc.com/event/hkmedicalfair/en/product?ref_source=GrayMenu&ref_medium=vep-tradeshowMedia enquiriesYuan Tung Financial Relations:Jasmine Zhang Tel: (852) 3428 3278 Email: jzhang@yuantung.com.hkLouise Song Tel: (852) 3428 5691 Email: lsong@yuantung.com.hkTiffany Leung Tel: (852) 3428 2361 Email: tleung@yuantung.com.hkHKTDC’s Communications & Public Affairs Department:Noah Qiu Tel (852) 2584 4575 Email: noah.yl.qiu@hktdc.orgNavin Law Tel: (852) 2584 4525 Email: navin.cm.law@hktdc.orgJane Cheung Tel: (852) 2584 4137 Email: jane.mh.cheung@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. [1] The product was published in the world-leading academic journal Nature Communications (2023). Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com